In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
Podden och tillhörande omslagsbild på den här sidan
tillhör DLA Piper. Innehållet i podden är skapat av DLA Piper och
inte av,
eller tillsammans med, Poddtoppen.
